第 1 到 11 筆結果,共 11 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer | TZU-TANG WEI ; Lin Y.-T.; Tang S.-P.; Luo C.-K.; Tsai C.-T.; CHIA-TUNG SHUN ; CHING-CHOW CHEN | Oncogene | 49 | 41 | |
2 | 2019 | Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress (Oncotarget (2019) 10 (3577-3578) DOI: 10.18632/oncotarget.1628) | Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Lin Y.-C.; Huang W.-C.; Huang L.-Y.; Lin Y.-T.; CHING-CHOW CHEN | Oncotarget | 0 | 0 | |
3 | 2017 | Corrigendum to “Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells” [Neoplasia (United States) 14 (2012) 463–475](S1476558612801023)(10.1596/neo.12300) | Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Chuang S.-H.; Chen K.-F.; ANN-LII CHENG ; CHING-CHOW CHEN | Neoplasia (United States) | 0 | 0 | |
4 | 2016 | Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer | TZU-TANG WEI ; Lin, Yi-Ting; Chen, Wen-Shu; Luo, Ping; Lin, Yu-Chin; CHIA-TUNG SHUN ; Lin, Yi-Hsin; Chen, Jhih-Bin; Chen, Nai-Wei; Fang, Jim-Min; MING-SHIANG WU ; KAI-CHIEN YANG ; LI-CHUN CHANG ; Tai, Kang-Yu; JIN-TUNG LIANG ; CHING-CHOW CHEN | EBioMedicine | 31 | 29 | |
5 | 2016 | Prevention of colitis and colitis-associated colorectal cancer by a novel polypharmacological histone deacetylase inhibitor | TZU-TANG WEI ; Lin, Y.-T.; Tseng, R.-Y.; CHIA-TUNG SHUN ; Lin, Y.-C.; MING-SHIANG WU ; Fang, J.-M. ; CHING-CHOW CHEN | Clinical Cancer Research | 25 | 27 | |
6 | 2015 | Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer | TZU-TANG WEI ; Lin, Yu-Chin; Lin, Pei-Hua; JIN-YUAN SHIH ; Chou, Chia-Wei; Huang, Wei-Jan; Yang, Yu-Chih; Hsiao, Pei-Wen; CHING-CHOW CHEN | Oncotarget | 12 | 12 | |
7 | 2015 | miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin | Chen W.-S.; Yen C.-J.; Chen Y.-J.; Chen J.-Y.; Wang L.-Y.; Chiu S.-J.; Shih W.-L.; Ho C.-Y.; TZU-TANG WEI ; Pan H.-L.; Chien P.-H.; Hung M.-C.; CHING-CHOW CHEN ; Huang W.-C. | Oncotarget | 34 | 32 | |
8 | 2014 | Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress | Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Lin Y.-C.; Huang W.-C.; Huang L.-Y.; Lin Y.-T.; CHING-CHOW CHEN | Oncotarget | 45 | 41 | |
9 | 2013 | Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase for cancer treatment | Chen, J.-B.; Chern, T.-R.; TZU-TANG WEI ; CHING-CHOW CHEN ; Lin, J.-H.; JIM-MIN FANG | Journal of Medicinal Chemistry | 62 | 62 | |
10 | 2013 | Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress | Yang P.-M.; Lin Y.-T.; CHIA-TUNG SHUN ; Lin S.-H.; TZU-TANG WEI ; Chuang S.-H.; MING-SHIANG WU ; CHING-CHOW CHEN | Scientific Reports | 59 | 55 | |
11 | 2012 | Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells | Lin Y.-C.; Wu M.-H.; TZU-TANG WEI ; Chung S.-H.; Chen K.-F.; ANN-LII CHENG ; CHING-CHOW CHEN | Neoplasia (United States) | 37 | 36 |